CaseMark Analyzing Investor Advisory Committees
Structures IAC/LPAC design with composition, authority scope, conflict review protocols, and valuation oversight.
When To Use
- Designing a new IAC or LPAC for a fund vehicle (private equity, venture, credit, real estate, infrastructure)
- Reviewing or benchmarking an existing committee's scope of authority against market terms
- Structuring conflict-of-interest review and consent protocols for GP-LP transactions
- Defining valuation oversight responsibilities and committee involvement in fair-value determinations
- Evaluating whether committee composition satisfies side-letter commitments or regulatory expectations
Inputs To Gather
- LPA / Partnership Agreement — current draft or executed version with IAC/LPAC provisions
- Side letters — any commitments granting specific LPs committee seats, observer rights, or enhanced consent rights
- Fund term sheet or PPM — stated committee authority, composition targets, and voting thresholds
- GP conflict-of-interest policy — existing framework for identifying, disclosing, and resolving conflicts
- Valuation policy — fund-level valuation methodology and any committee role in override or escalation
- Investor base profile — LP types (pension, sovereign wealth, endowment, fund-of-funds, family office), commitment sizes, and governance expectations
- Regulatory considerations — jurisdiction-specific rules affecting committee authority (e.g., ERISA plan asset rules, AIFMD requirements) [VERIFY]
Workflow
- Map existing provisions — Extract all IAC/LPAC references from the LPA, side letters, and PPM. Catalog each grant of authority, consent right, and information right.
- Analyze committee composition
- Identify seat allocation criteria: commitment size thresholds, LP-type diversity requirements, independent member slots
- Flag whether any single LP or LP bloc holds a controlling number of seats
- Confirm whether side-letter most-favored-nation (MFN) clauses could expand committee membership beyond planned size
- Define authority scope — Classify each committee power:
- Consent rights — transactions requiring affirmative LPAC approval (affiliated co-investments, GP-led secondaries, cross-fund investments, principal transactions, allocation of broken-deal expenses)
- Advisory/consultation rights — matters where GP must seek input but retains final decision authority (extension of fund term, key-person replacement, changes to investment strategy)
- Waiver authority — conflicts the committee may waive on behalf of all LPs vs. conflicts requiring full LP consent [VERIFY jurisdiction-specific fiduciary implications]
- Evaluate conflict review protocols
- Confirm the disclosure standard: does the GP provide full disclosure of material facts or a summary notice?
- Check response mechanics: deemed-consent timelines, quorum requirements, voting thresholds (majority vs. supermajority), recusal rules for conflicted members
- Assess whether the LPA specifies consequences of committee failure to respond (deemed approval vs. deemed denial)
- Assess valuation oversight role
- Determine committee involvement: review-only, consent to methodology changes, approval of write-downs/write-ups above a materiality threshold
- Evaluate interaction with third-party valuation agents and audit firm reliance on committee determinations
- Flag any provisions where committee valuation authority could create LP liability or co-fiduciary risk [VERIFY under applicable partnership law]
- Benchmark against market standards — Compare committee terms to current market norms for the fund's strategy and vintage. Note deviations that may attract LP pushback or give the GP unusual discretion.
- Identify structural risks — Flag gaps such as absence of indemnification for committee members, no confidentiality obligations, lack of expense-reimbursement provisions, or missing procedures for replacing departing members.
Output
Produce a structured analysis report containing:
- Committee composition summary — seat count, allocation methodology, current or proposed members, and term/rotation mechanics
- Authority matrix — table mapping each conflict or decision category to the applicable committee power (consent, advisory, waiver, none) with LPA section references
- Conflict review process map — step-by-step flow from GP disclosure through committee response, including timelines and default outcomes
- Valuation oversight summary — committee role relative to GP, third-party valuers, and auditors
- Market-comparison notes — key deviations from prevailing market terms with risk commentary
- Recommendations — specific drafting or structural changes to address identified gaps or risks
Quality Checks
- Every committee power cited traces to a specific LPA section or side-letter provision
- Consent vs. advisory vs. waiver authority is clearly distinguished — no conflation of categories
- Deemed-consent mechanics and quorum rules are fully specified (not left ambiguous)
- Side-letter MFN effects on composition and authority are accounted for
- [VERIFY] markers applied to all jurisdiction-dependent points: fiduciary standards for committee waiver authority, ERISA plan-asset implications, tax-exempt investor constraints, and non-U.S. regulatory requirements
- Valuation oversight analysis addresses whether committee involvement creates unintended liability exposure for sitting members
- Recommendations are concrete and drafting-ready, not abstract policy suggestions